Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This trial aims to determine whether Jiangzhong Hou Gu® Mi Xi™ is an effective intervention
to improve symptoms and indicators in patients with spleen qi deficiency and peptic ulcer
diseases.
Phase:
N/A
Details
Lead Sponsor:
Jiangxi University of Traditional Chinese Medicine
Collaborators:
Fengcheng Hospital of Traditional Chinese Medicine Fengcheng People's Hospital Jiangxi Hospital of Traditional Chinese Medicine Jiujiang Hospital of Traditional Chinese Medicine Jiujiang No.1 People's Hospital Nanchang Hongdu Hospital of Traditional Chinese Medicine Nanchang Hospital of Integrated Traditional Chinese and Western Medicine Second Affiliated Hospital of Nanchang University The First Affiliated Hospital of Nanchang University The Nanchang Third Hospital The Third Affiliated Hospital of Nanchang University Xinyu Hospital of Traditional Chinese Medicine Xinyu People's Hospital